285 related articles for article (PubMed ID: 24610782)
1. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).
Kim SJ; Cho J; Song EJ; Kim SJ; Kim HM; Lee KE; Suh SW; Kim EE
J Biol Chem; 2014 May; 289(18):12264-74. PubMed ID: 24610782
[TBL] [Abstract][Full Text] [Related]
2. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD).
Lee JJ; Park JK; Jeong J; Jeon H; Yoon JB; Kim EE; Lee KJ
J Biol Chem; 2013 Mar; 288(10):6998-7011. PubMed ID: 23293021
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray crystallographic analysis of the complex between the N-D1 domain of VCP from Homo sapiens and the N domain of OTU1 from Saccharomyces cerevisiae.
Kim SJ; Kim EE
Acta Crystallogr F Struct Biol Commun; 2014 Aug; 70(Pt 8):1087-9. PubMed ID: 25084388
[TBL] [Abstract][Full Text] [Related]
4. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
5. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.
Hänzelmann P; Schindelin H
J Biol Chem; 2011 Nov; 286(44):38679-38690. PubMed ID: 21914798
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
[TBL] [Abstract][Full Text] [Related]
7. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein.
Messick TE; Russell NS; Iwata AJ; Sarachan KL; Shiekhattar R; Shanks JR; Reyes-Turcu FE; Wilkinson KD; Marmorstein R
J Biol Chem; 2008 Apr; 283(16):11038-49. PubMed ID: 18270205
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
10. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
11. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
Vij N
J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
[TBL] [Abstract][Full Text] [Related]
12. An Armadillo motif in Ufd3 interacts with Cdc48 and is involved in ubiquitin homeostasis and protein degradation.
Zhao G; Li G; Schindelin H; Lennarz WJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16197-202. PubMed ID: 19805280
[TBL] [Abstract][Full Text] [Related]
13. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of the PLAA/Ufd3-p97/Cdc48 complex.
Qiu L; Pashkova N; Walker JR; Winistorfer S; Allali-Hassani A; Akutsu M; Piper R; Dhe-Paganon S
J Biol Chem; 2010 Jan; 285(1):365-72. PubMed ID: 19887378
[TBL] [Abstract][Full Text] [Related]
16. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
Wang Q; Song C; Yang X; Li CC
J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
[TBL] [Abstract][Full Text] [Related]
17. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
Zhong X; Pittman RN
Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
[TBL] [Abstract][Full Text] [Related]
19. A Retrotranslocation Assay That Predicts Defective VCP/p97-Mediated Trafficking of a Retroviral Signal Peptide.
Das P; Xu WK; Gautam AKS; Lozano MM; Dudley JP
mBio; 2022 Feb; 13(1):e0295321. PubMed ID: 35089078
[TBL] [Abstract][Full Text] [Related]
20. The general definition of the p97/valosin-containing protein (VCP)-interacting motif (VIM) delineates a new family of p97 cofactors.
Stapf C; Cartwright E; Bycroft M; Hofmann K; Buchberger A
J Biol Chem; 2011 Nov; 286(44):38670-38678. PubMed ID: 21896481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
